drugset
drugset / Trial / NCT07256600

PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers

NCT07256600 ↗

Phase 1 Completed 70 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelTreatment

Summary

A bioequivalence study comparing DWJ1445 and DWC202506 in healthy adults

Timeline

Start
2025-11-14
Primary completion
2025-11-23
Completion
2025-12-02

Drugs

EvaluationDrugModalityDoseRoute
Subject DWC202506 Unknown — Oral
Subject DWJ1445 Unknown — Oral

Indications

No indication recorded.